ATAI News and Press, ATAI Life Sciences N.V. From 11/15/23

Psychedelics have been subject to significantly increased attention from the medical and scientific communities in recent years due to claims of their medical efficacy against various mental health conditions. While a majority of psychedelic compounds are still illegal at the federal level and in...

2023-11-14 07:28:21 ET More on ATAI Life Sciences Atai Life Sciences: RL-007, Targeting Schizophrenia Subpopulation With No FDA Approved Therapies Psychedelic drugs market to break $7B in 2029 led by these 3 meds Psychedelics research amendments advance in House comm...

Phase 2b study of RL-007 in CIAS patients continues to be on track to report data in 2H 2024 and data from the EMP-01 (MDMA derivative) Phase 1 study is anticipated to report out later this year. Phase 1 data of VLS-01 (a proprietary oral transmucosal film formulation of DMT) demonstrated...

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

ATAI Life Sciences N.V. (ATAI) is expected to report $-0.2 for Q3 2023

Individuals who take part in ayahuasca ceremonies regularly reported fewer chronic and lifestyle-related diseases, increased physical activity, better diets and improved well-being compared to the general population. A recent study from the Netherlands has found that regular ayahuasca ceremony ...

Recent advancements in virtual technology may have applications in psychedelic-assisted therapy. Both are relatively new fields that have attracted lots of attention in recent years thanks to their potentially game-changing applications. Psychedelic-assisted therapy has shown it has the potenti...

A federal appeals court panel has begun hearing arguments in a case involving a Seattle doctor who sued the U.S. Drug Enforcement Administration for denying his patients access to psilocybin therapy and who is now asking the federal government to reschedule the psychedelic. The suit is part of ...

A surge of psychedelic research has significantly increased the public appeal of psychedelics in recent years. Researchers have discovered that several psychedelics have the potential to treat various mental-health disorders safely and effectively, making them possible alternatives for convention...

2023-10-17 09:05:31 ET More on KKR & Co. KKR: Looking Ahead To Higher Activity, Better Earnings In 2024 KKR, Flerie to form new pharma services platform Frontier Biosolutions Circor falls on report France probing KKR's planned deal over defense concerns F...